To compare the overall and disease-specific mortality of Croatian male athletes who won one or more Olympic medals representing Yugoslavia from 1948 to 1988 or Croatia from 1992 to 2016, and the general Croatian male population standardized by age and ...
Percutaneous transluminal coronary angioplasty with drug-coated balloons (DCBs) is the modality of coronary artery revascularization with local application of antiproliferative agents, paclitaxel or sirolimus. It has become an appealing alternative to drug-eluting stents (DESs) due to intervention simplification, absence of permanent metallic mesh implantation, preserved vasomotion, and shorter duration of dual antiplatelet therapy because of reduced risk of acute thrombosis. Numerous studies have assessed DCB safety and efficacy for various aspects of coronary artery disease (CAD) for in-stent restenosis (ISR) and de novo CAD, while interventional cardiologists worldwide report good results with DCB in everyday practice. However, data is not robust enough to recommend DCB according to the European Society of Cardiology guidelines, except for the ISR of bare-metal stents (BMSs). At the same time, the United States Food and Drug Administration approved the DCB usage for ISR of both BMS and DES in March 2024. Further studies are underway to increase the body of evidence, and new technologies, including DCB with combined paclitaxel and sirolimus, are developing.
This article is a narrative review based on literature search primarily on PubMed about connections of physical activity and cardiovascular health. Moderate physical activity increases life expectancy and provides numerous cardiovascular benefits. It reduces the risk of atherosclerosis, atrial fibrillation (AF) incidence, arterial hypertension, hyperlipidemia, and diabetes. Accordingly, the World Health Organization guidelines recommend a minimum of 150 min of moderate physical activity or 75 min of vigorous physical activity per week, or a combination of the intensities of appropriate duration, for adults aged 18–64 years. For additional beneficial health effects, 300 or more minutes of moderate physical activity or 150 or more minutes of vigorous physical activity, with the option of combining training intensities, are recommended. On the other hand, evidence on vigorous physical activity is less clear, and evidence is more conflicting. There is a hypothesis that intense exercise may harm the cardiovascular system, causing enlargement of all heart chambers, myocardial fibrosis (primarily of the right ventricle), and increasing the risk, of coronary artery calcification, AF, and sudden cardiac death. Despite recent advancements, there is no firm evidence on the clinical significance of these conditions. Hence, current recommendations do not advise specific exercise intensity limits. The most important sports medicine task is identifying the athletes with an unacceptably high risk of triggering sudden cardiac death during sports activity and advising them with appropriate recommendations.